Filter Search


Healthcare and Medical


Location Summary Deadline
Germany Conclusion Of Discount Agreements According To § 130 A Abs. 8 Sgb V In The Form Of Active Substance-related Framework Agreements For Certain Finished Medicinal Products. Tranexamic Acid (ilo) - Dak-g, Kkh 2025-12-03
Germany Conclusion Of Discount Agreements According To § 130 A Abs. 8 Sgb V In The Form Of Active Substance-related Framework Agreements For Certain Finished Medicinal Products. Naproxen - Dak-g, Kkh 2025-12-03
Germany Conclusion Of Discount Agreements According To § 130 A Abs. 8 Sgb V In The Form Of Active Substance-related Framework Agreements For Certain Finished Medicinal Products. Biperiden 2025-12-03
Germany Conclusion Of Discount Agreements According To § 130 A Abs. 8 Sgb V In The Form Of Active Substance-related Framework Agreements For Certain Finished Medicinal Products. Tranexamic Acid 2025-12-03
Germany Conclusion Of Discount Agreements According To § 130 A Abs. 8 Sgb V In The Form Of Active Substance-related Framework Agreements For Certain Finished Medicinal Products. Rizatriptan (tab) 2025-12-03
Germany Conclusion Of Discount Agreements According To § 130 A Abs. 8 Sgb V In The Form Of Active Substance-related Framework Agreements For Certain Finished Medicinal Products. Brimonidine (atr) 2025-12-03
Germany Conclusion Of Discount Agreements According To § 130 A Abs. 8 Sgb V In The Form Of Active Substance-related Framework Agreements For Certain Finished Medicinal Products. Tranexamic Acid 2025-12-03
Germany Conclusion Of Discount Agreements In Accordance With § 130 A Abs. 8 Sgb V In The Form Of Active Substance-related Framework Agreements For Certain Finished Medicinal Products. Sulpirid - Dak-g, Kkh 2025-12-03
Germany Conclusion Of Discount Agreements According To § 130 A Abs. 8 Sgb V In The Form Of Active Substance-related Framework Agreements For Certain Finished Medicinal Products. Betahistin - Dak-g, Kkh 2025-12-03
Germany Conclusion Of Discount Agreements In Accordance With § 130 A Abs. 8 Sgb V In The Form Of Active Substance-related Framework Agreements For Certain Finished Medicinal Products. Terazosin 2025-12-03
Whats app